Calculate Your RTM Revenue: A Simple Framework

Most practices that evaluate RTM underestimate their revenue potential because they start with the wrong number. They look at the per-code reimbursement rate — $50 for a device supply code, $70 for a treatment management code — and conclude the return is modest. The calculation that actually captures the RTM opportunity is multiplicative, not additive, and it looks entirely different when you run it correctly. Here is the framework, with real numbers, that practice administrators can apply to their own patient panels in about 15 minutes.

Step 1: Identify Your Eligible Patient Panel

RTM eligibility depends on diagnosis category and active treatment status. For musculoskeletal RTM under CPT 98977, the eligible population is patients with active musculoskeletal diagnoses under treatment — this includes post-surgical rehabilitation patients, chronic pain patients, and patients in active physical or occupational therapy programs. For behavioral health RTM under CPT 98978, the eligible population is patients in active behavioral health treatment with a qualifying diagnosis. For respiratory RTM under CPT 98976, patients with monitored respiratory conditions qualify.

In most outpatient practices, the RTM-eligible fraction of the active patient panel falls between 40% and 70%. A physical therapy practice is close to 100% eligible, since virtually every PT patient has a qualifying musculoskeletal condition. A pain management practice typically sees 60% to 80% of its active panel as eligible. A behavioral health practice may see 50% to 70% eligibility depending on diagnosis mix and treatment intensity.

For this calculation, use your active patient panel — patients seen at least once in the past 90 days — as your starting number. If you have 300 active patients and estimate 60% eligibility, your eligible panel is 180 patients. Write that number down. It is the ceiling from which every other calculation flows.

Step 2: Estimate Your Enrollment Rate

Not every eligible patient will enroll in RTM. The enrollment rate depends on how the program is presented, the simplicity of the technology, and how consistently the enrollment conversation happens across providers and staff. For a practice launching RTM for the first time, a realistic first-six-month enrollment target is 35% to 50% of the eligible panel. Practices with strong patient communication infrastructure and simple app-based monitoring can achieve 50% to 60%. Practices with technology friction or inconsistent provider engagement typically land at 20% to 30%.

Use 45% as your baseline estimate if you have no prior data. Applying 45% to an eligible panel of 180 patients gives you 81 enrolled patients. This is the number that generates monthly billing. Every percentage point of enrollment improvement is worth approximately two additional patients in the panel at this scale — about $280 in additional monthly revenue per point of enrollment improvement, or $3,360 annually.

Step 3: Calculate Monthly Reimbursement Per Patient

Monthly RTM reimbursement per enrolled patient comes from two primary codes billed each month: the device supply code (98977 for musculoskeletal, 98978 for behavioral health) and the treatment management code (98980). A third code, 98981, applies in months where more than 20 minutes of treatment management is documented for that patient.

Under Medicare in 2026, 98977 reimburses approximately $48 per month and 98980 reimburses approximately $62 per month. The combination of these two codes generates roughly $110 per enrolled patient per month as a baseline. In months where 98981 is also billed, the per-patient total rises to approximately $160. Averaging across months with and without the additional increment, a realistic per-patient monthly average is $130 to $145 under Medicare.

Commercial payer reimbursement varies significantly. Major commercial payers that cover RTM generally reimburse at rates comparable to or slightly higher than Medicare. Some payers require prior authorization, which adds administrative overhead. A blended rate of $140 per patient per month is a conservative estimate for a practice with a mixed Medicare and commercial payer mix where RTM coverage is confirmed for the majority of enrolled patients.

Step 4: Run the Full Calculation

With the three inputs established, the monthly RTM revenue calculation is straightforward. Using the numbers from the example above: 300 active patients, 60% eligible, 45% enrollment rate, $140 per patient per month. That is 300 multiplied by 0.60 to get 180 eligible patients, multiplied by 0.45 to get 81 enrolled patients, multiplied by $140 to get $11,340 per month in RTM revenue. At that run rate, annual RTM revenue is $136,080.

The startup cost for an RTM program is minimal relative to this revenue. A software subscription for an RTM platform typically runs $500 to $1,500 per month depending on the vendor and the size of the enrolled panel. There is no capital equipment investment required for app-based RTM. The payback period is typically within the first month of billing, because the monthly revenue from even a small enrolled panel exceeds the monthly platform cost.

What Staffing Is Required

The most common staffing question from practices evaluating RTM is how much clinical staff time the program actually requires. For a panel of 81 enrolled patients, the monthly treatment management time requirement is approximately 81 patients multiplied by an average of 25 minutes per patient (allowing for some months with additional management time), which equals roughly 34 hours of staff time per month. At a fully-loaded clinical staff cost of $30 per hour, that is $1,020 in labor cost against $11,340 in monthly revenue.

In practice, many practices assign RTM monitoring to a part-time RTM coordinator — a role that combines patient engagement, data review, and billing workflow management. At 80 enrolled patients, this role typically requires 15 to 20 hours per week. Some practices assign this work to an existing medical assistant or clinical coordinator as a defined portion of their weekly responsibilities rather than creating a new position.

Revenue Leak Points and How to Avoid Them

Several common revenue leak points reduce RTM revenue below the theoretical maximum. The first is the 16-day compliance gap: patients who fall below the 16-day data threshold in a given month cannot be billed for that month’s device supply code. Practices that do not actively monitor daily compliance and re-engage patients who are falling behind lose 10% to 20% of device supply revenue to this leak. Active engagement with patients who fall behind on data logging reduces the leak to below 5%.

The second leak point is missed codes. Failing to bill 98975 in the enrollment month, consistently missing 98981 in months where additional management time is documented, or billing only one code in the series instead of all eligible codes reduces per-patient revenue significantly. A billing checklist run at the end of each billing period closes this gap.

The third and largest leak point is stagnant enrollment. A panel that reaches 45% enrollment in month 3 and stays there for the rest of the year leaves the revenue potential of the remaining eligible patients permanently uncaptured. RTM enrollment is not a one-time campaign — it is an ongoing operational process. New patients entering the practice are eligible immediately. Patients who declined initially should be re-offered enrollment when their clinical circumstances change. Treating enrollment as a living metric with a monthly target, rather than a launch initiative that ends, is what separates high-revenue RTM programs from stagnant ones.

Phasing the Rollout

Practices that try to launch RTM for their entire eligible panel simultaneously typically underperform compared to practices that phase the rollout. A phased approach starts with 20 to 30 patients — ideally the most engaged and tech-comfortable subset of the eligible panel — and uses the first 60 days to validate the workflow, identify documentation gaps, and confirm billing processes are functioning correctly. After validating with the initial cohort, enrollment expands in waves of 20 to 30 patients per month until the target enrollment rate is reached.

The phased approach produces better outcomes because the practice enters the high-volume enrollment phase with a workflow that has already been tested and refined. A practice that enrolls 80 patients in month one with an untested workflow spends months one through three fixing process problems while those patients generate inconsistent data and documentation. A practice that enrolls 25 patients and refines the workflow before scaling has a consistent, auditable program by the time it reaches scale.

Run your own numbers. The inputs are your active panel size, your eligibility estimate, a realistic enrollment rate, and the reimbursement rate for your payer mix. Whatever number you arrive at, it represents revenue your practice is currently generating zero dollars from. The investment to capture it is a software subscription and a part-time coordinator role. That math works at almost any practice size with a qualifying patient population.

Sensitivity Analysis: What Drives the Number Up or Down

The per-patient monthly reimbursement rate is relatively stable and outside the practice’s control — it is set by Medicare and commercial payer contracts. The two variables that most dramatically affect total RTM revenue and are fully within the practice’s control are enrollment rate and 16-day compliance rate. Understanding how these variables interact illuminates where to focus operational attention.

Consider a practice with 200 eligible patients and a $130 per patient per month blended reimbursement rate. At 30 percent enrollment and 70 percent monthly compliance, the practice has 60 enrolled patients, of whom 42 are generating billable revenue in any given month: $5,460 per month, $65,520 per year. At 50 percent enrollment and 85 percent compliance, the practice has 100 enrolled patients, of whom 85 are billing monthly: $11,050 per month, $132,600 per year. The difference between 30 percent enrollment and 50 percent enrollment, combined with improved compliance, is $67,000 per year in additional annual revenue — from the same patient population, with the same reimbursement rates.

This sensitivity analysis makes the operational investment priorities clear. Every percentage point of enrollment improvement at this scale adds approximately $2,600 in annual revenue. Every percentage point of compliance improvement adds approximately $1,300 in annual revenue. The enrollment improvement is twice as valuable as the compliance improvement, which should guide where the practice invests its operational attention first.

The Startup Period vs. Steady State

RTM revenue in the first three months of a program launch is not representative of steady-state revenue. The startup period involves building the enrolled panel from zero, which means monthly revenue grows as enrollment grows rather than arriving at full run-rate immediately. Practices that evaluate RTM ROI at the end of month two are typically disappointed because they are measuring the startup ramp, not the program at scale.

A more useful evaluation framework looks at months six through twelve, when enrollment should be approaching the target rate and monthly billing has reached a consistent pattern. The revenue profile of a well-implemented RTM program looks like a ramp followed by a plateau: months one through four are the ramp, month five is approximately half-run-rate, and months six through twelve represent the program operating at or near its designed capacity.

Practices that set their ROI expectations based on the full-program steady state rather than the early-ramp period are less likely to abandon RTM programs before they reach scale. A program that is generating $2,500 per month at month two and $9,000 per month at month eight is not underperforming at month two — it is on the expected trajectory. The practices that cancel RTM programs in month three because “the revenue isn’t there” are abandoning programs that would have paid back the investment many times over if allowed to reach scale.

How to Present RTM ROI to Practice Leadership

Practice managers and operations directors proposing RTM programs to physicians, medical directors, or practice administrators need a clear financial presentation that answers the questions leadership actually asks. The most common questions:

• “What does it cost to run this program?” Platform cost plus staffing cost. For most practices, the monthly operating cost of an RTM program at scale runs $1,500 to $4,000 — platform subscription plus 10 to 20 hours of coordinator time per month.
• “What is the payback period?” For a practice with 60 enrolled patients at $130/month average, revenue of $7,800/month against operating cost of $2,500/month produces net revenue of $5,300/month. Initial setup investment of $3,000 to $5,000 is recovered in less than one month of operation.
• “What is the compliance and audit risk?” With proper documentation workflows, RTM is a low-audit-risk billing category. The risk is concentrated in programs that bill without confirming eligibility thresholds — a workflow problem, not an inherent program risk.
• “What clinical benefit are we providing?” Between-visit monitoring that catches deterioration earlier, improves treatment adherence, and gives providers better information at each visit. RTM programs in physical therapy, pain management, and behavioral health have published outcome data showing measurable improvements in patient-reported outcomes compared to visit-only care.

The financial case for RTM is straightforward when presented correctly. The challenge in most practices is not convincing leadership that RTM is financially viable — it is ensuring that the program is implemented well enough to actually hit the revenue projections. That implementation quality is the variable that determines whether RTM becomes a significant revenue stream or a modest one.